Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

Clinical Nephrology

Volumn 52, Issue 5, 1999, Pages 293-296

  Yorioka, N ^a   Taniguchi, Y ^a   Amimoto, D ^a   Ogata, S ^a   Sakikubo, E ^a   Yamakido, M ^a   Naito, T ^b   Shimamoto, F ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cellular crescent; Crescentic glomerulonephritis; Hypoalbuminemia; Myeloperoxidase anti neutrophil cytoplasmic antibody; Renal dysfunction

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; MIZORIBINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; SERUM ALBUMIN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; KIDNEY DISEASE; MALE; PLASMAPHERESIS; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SURVIVAL RATE;

EID: 0032741197     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bistrian BR 1998 Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis 32 (Suppl 4): S113-S117
2. De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD 1995 Relationship between disease activity and antineutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 25: 380-389
3. Falk RJ 1990 ANCA-associatedrenal disease. Kidney Int 38: 998-1010
4. Falk RJ, Jennette JC 1988 Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657
5. Falk RJ, Jennette JC 1997 ANCA small-vessel vasculitis. J Am Soc Nephrol 8: 314-322
6. Ferrario F, Tadros MT, Napodano P, Sinico RA, Fellin G, D'Amico G 1994 Critical re-evaluation of 41 cases of "idiopathic" crescentic glomerulonephritis. Clin Nephrol 41: 1-9
7. Hagen EC, Andrassy K, Chernok E, Doha MR, Gaskin G, Gross W, Lesavre P, Lüdemann J, Pusey CD, Rasmussen N, Savage COS, Sinico A, Wilk A, van der Woude FJ 1993 The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study of the standardization or ANCA assays. J Immunol Methods 159: 1-16
8. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K 1993 Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44: 1086-1090
9. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC 1994 Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 46: 1-15
10. Kobayashi K, Shibata T, Sugisaki T 1995 Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47: 454-463
11. Pettersson E, Heigl Z 1992 Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 37: 219-228
12. Schnabel A, Hauschild S, Gross WL 1996 Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol 109: 201-206